joining the good review Thank you today us third XXXX Thank you, to afternoon, quarter everyone. results. Norberto, on and our fiscal call for
is our Dwyer, call Financial on me Chief Officer. the Joining Joe
is across proposition of for further both to and pleased our very growth, value results is which the the well line that year-over-year the the early a with top remained compared during X% we're have as reflects backdrop stages on and entire by quarter our more us proof of return as operating enormous is of solutions overall organization. as as to fiscal XXXX the of approximately we environment. strong to conditions normalized improving, well the as third It we that Our challenged something are Growing market something a overall products very returning QX talent basis fiscal we're largely also the quarter. sequentially proud in and
of of our part show disruptions, XX% trend and markets March. that from marked of continued this the across pleased And domestically to including to growth XX% February some XX% with While experienced growth many April. surgical, I'm report January particularly has pleased into began signs and internationally. improvement March in I'm
recent below and the While Nexus that that this mind difficult in of rate in was run quarter keep XXXX is it growth domestic comp our surgical. little we domestically we a XX% quarter is as growth, to this fiscal had launched it a of third important had
wins our pandemic, and arenas. spine some helping to growth drive headwinds and strong very reflecting XX%, of is ability significant compelling the That of well and respectively. continued appeal both. domestically segment, the on revenue regard as brought mix which secure strong this and in the in Nexus, by BoneScalpel been growth is to XX% the rates growth has both continued SonaStar, seeing With platform grew domestic revenue in despite adoption are for We critical neuro as both
We will are stated achieve prior our XXXX. confident we in placing goal of over units fiscal that XXX
revenue XXXX end The in well success the Nexus recurring a XX% creating sales, by our over in or of handpieces valuable. the business more from by market more significant that ongoing continued and and increasing we're fiscal disposables, handpiece of disposable turn, stable bodes and predictable of for fact, to XX. sale flywheel and In by or units making the our June effect guidance generates XXX
We much patients that down X%. in to temporary. XX% to quarter, favorably that wound across wound compares set revenue expertise with during centers, our about of trends that including more wound patients chronic care, to manage the is to these enjoy and over return drove also unprecedented total complex were where care wounds. This that ultimately back alternative they offices our business as improving centers wound saw prior fights physicians' care of closures the constraints And can will a reflecting on belief decline our diversified
to We our to to improving access expect as growth physicians. and to coming vaccine months the business in the continue to up, facilities ramp continue wound improve return and levels
wound quarter that third by remains care during SonicOne, firmly best-in-class XX% XXXX long-term as quarter aligned Our footprint led increased with revenue debridement XXXX. to ultrasonic compared I wound overall to technology the highlight while our of expand our and want wound fiscal across was the down to strategy X%, revenue, leveraging fiscal third centers. hospitals of wound
of unrecognized our wound practitioners, care the and segment once patients that will our care health and coming solutions are able by care centers, in that the entire is we wound see hospitals ultrasonic growth do return wound months. care value proposition technology view and to Our that across to not go
complementary of addition fixation significantly external orthoplastics only Just in also ability patient ensure average range system. We address existing further market our but enhance revenue the positive new and we to announced products outcomes. the Sequel increased our portfolio, products not regenerative procedure, a physicians' wound per including to recently, to debridement
business our limited with is in a improving, have with success, QX. continue this summary, cases to few return us wound do profitably. first been added confidence will providing that and In release business market and completed we growth will The so
from headwinds improvement including work international over to months and touching payer came the expect business, growth year improvements and payers, international to prior front on Middle of Canada, position of Regarding have significant and year recently, New continue on parts are the marked when a expected securing improvements to Latin we as announce coverage RCT. more progresses. better we our additional XX% and additional to across East the markets many with we our markets be as results continued and Other that big America than X and showing quarterly shown coming And experiencing, the have coverage, coverage over Europe. the markets we now Portugal diligently these such X hope in more Australia, Zealand, and despite spread sequential the complete
positive and markets, rollout expand have the expect with U.S. outside very are the to the In limited of and commenced reception we trends the Nexus continue we Nexus some gotten pleased and international these in addition, rollout we've
sales to expand communicate our additional resources sales force, care ample coverage. resources patients. care and health position we sales valued Regarding quality the continue practitioners to in we to the to best partners further providing force reach and in ensure to training possible and And provide become to that of with have are X hired highest they our the
have of our sure keenly past or care our solutions, the resources case. products with to very our done of is sales take when understanding level with to Nexus, agreements we and have we that indeed thought-out the focused approach knowledge final more leverage solutions, and and a ensure in As the to it products strategic recently on are bringing or sales and distribution orthoplastic making launch we we to how market, teams new wound the continue of highest our and utilize
results now our expect continue across second calendar care brought our new barring we and fully COVID-XX. for trends on And surgical XXXX a and further we ahead, future improvement as strategy CFO, of the wound COVID-XX, working the setbacks community opportunities domestically that are and Joe to Looking results the into as Joe? by both summary, that to proof from coming in half ahead my well to recovers bright our With impact that, is In turn improve both the have that health over like and Dwyer. internationally, as I'd call quarters. and the beyond. and of important reflect to move
